Harvard Testosterone Therapy and Sexual Dysfunction 2026

Testosterone therapy is one of the most controversial topics in medicine, yet multiple medical societies endorse its use, supported by level 1 evidence showing a variety of health benefits in men. This innovative and comprehensive course will focus on testosterone deficiency and its treatment in men and women and will also address several other sexual issues. Studies indicate that nearly 40% of men over the age of 45 have overtly low testosterone levels, yet education in this area is extremely limited. Similarly, there have been few educational opportunities to address sexual dysfunction in men and women. Approximately 40% of men and a similar percentage of women have one sexual dysfunction or another. Indeed, there have been several fascinating therapeutic advances in the treatment of sexual dysfunction in women that have received scant attention in other educational events.

Program Highlights Include:

• NEW! Important FDA Labeling Updates
• The importance of testosterone in male health
• Can testosterone be used in men with prostate cancer?
• Current evidence regarding HRT in women and how to start treatment
• The who, when and why of testosterone therapy
• Evaluation of and cutting-edge treatment for ED
• The TRAVERSE Trial results
• Hair and hormones
• Non-medical strategies for managing couples with sexual complaints

Who Should Attend

• Dermatologists
• Endocrinologists
• Family practice providers
• Geriatricians
• Gynecologists
• PAs
• Primary care providers
• Psychiatrists
• Psychologists
• NPs and nurses
• Urologists
• Other clinicians who treat low testosterone and male and female sexual health issues